These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 12097384

  • 1. Tumor-infiltrating CD4+ T lymphocytes express APO2 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on APO2L/TRAIL expression and -mediated cytotoxicity.
    Dorothée G, Vergnon I, Menez J, Echchakir H, Grunenwald D, Kubin M, Chouaib S, Mami-Chouaib F.
    J Immunol; 2002 Jul 15; 169(2):809-17. PubMed ID: 12097384
    [Abstract] [Full Text] [Related]

  • 2. Antitumor cytotoxic T-lymphocyte response in human lung carcinoma: identification of a tumor-associated antigen.
    Mami-Chouaib F, Echchakir H, Dorothée G, Vergnon I, Chouaib S.
    Immunol Rev; 2002 Oct 15; 188():114-21. PubMed ID: 12445285
    [Abstract] [Full Text] [Related]

  • 3. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
    Seki N, Brooks AD, Carter CR, Back TC, Parsoneault EM, Smyth MJ, Wiltrout RH, Sayers TJ.
    J Immunol; 2002 Apr 01; 168(7):3484-92. PubMed ID: 11907109
    [Abstract] [Full Text] [Related]

  • 4. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release.
    Röhn TA, Wagenknecht B, Roth W, Naumann U, Gulbins E, Krammer PH, Walczak H, Weller M.
    Oncogene; 2001 Jul 12; 20(31):4128-37. PubMed ID: 11464279
    [Abstract] [Full Text] [Related]

  • 5. Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival.
    Jin H, Yang R, Fong S, Totpal K, Lawrence D, Zheng Z, Ross J, Koeppen H, Schwall R, Ashkenazi A.
    Cancer Res; 2004 Jul 15; 64(14):4900-5. PubMed ID: 15256461
    [Abstract] [Full Text] [Related]

  • 6. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Pollack IF, Erff M, Ashkenazi A.
    Clin Cancer Res; 2001 May 15; 7(5):1362-9. PubMed ID: 11350907
    [Abstract] [Full Text] [Related]

  • 7. Role of Fas and granule exocytosis pathways in tumor-infiltrating T lymphocyte-induced apoptosis of autologous human lung-carcinoma cells.
    Dorothee G, Ameyar M, Bettaieb A, Vergnon I, Echchakir H, Bouziane M, Chouaib S, Mami-Chouaib F.
    Int J Cancer; 2001 Mar 15; 91(6):772-7. PubMed ID: 11275978
    [Abstract] [Full Text] [Related]

  • 8. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN, Dedoussis GV, Papadopoulos NG, Missitzis I, Stathopoulos GP, Papamichail M.
    Cancer; 1994 Aug 15; 74(4):1275-82. PubMed ID: 7914469
    [Abstract] [Full Text] [Related]

  • 9. TNF-related apoptosis-inducing ligand death pathway-mediated human beta-cell destruction.
    Ou D, Metzger DL, Wang X, Huang J, Pozzilli P, Tingle AJ.
    Diabetologia; 2002 Dec 15; 45(12):1678-88. PubMed ID: 12488957
    [Abstract] [Full Text] [Related]

  • 10. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.
    Frese S, Frese-Schaper M, Andres AC, Miescher D, Zumkehr B, Schmid RA.
    Cancer Res; 2006 Jun 01; 66(11):5867-74. PubMed ID: 16740726
    [Abstract] [Full Text] [Related]

  • 11. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.
    Saha A, Chatterjee SK, Foon KA, Bhattacharya-Chatterjee M.
    Immunology; 2006 Aug 01; 118(4):483-96. PubMed ID: 16895556
    [Abstract] [Full Text] [Related]

  • 12. MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).
    Wang P, Vánky F, Klein E.
    Int J Cancer; 1992 Jul 30; 51(6):962-7. PubMed ID: 1386348
    [Abstract] [Full Text] [Related]

  • 13. Evidence for in situ expansion of diverse antitumor-specific cytotoxic T lymphocyte clones in a human large cell carcinoma of the lung.
    Echchakir H, Vergnon I, Dorothée G, Grunenwald D, Chouaib S, Mami-Chouaib F.
    Int Immunol; 2000 Apr 30; 12(4):537-46. PubMed ID: 10744655
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inhibitory protein.
    Frese S, Brunner T, Gugger M, Uduehi A, Schmid RA.
    J Thorac Cardiovasc Surg; 2002 Jan 30; 123(1):168-74. PubMed ID: 11782771
    [Abstract] [Full Text] [Related]

  • 15. Human CD8+ T cell blasts are more sensitive than CD4+ T cell blasts to regulation by APO2L/TRAIL.
    Bosque A, Pardo J, Martínez-Lorenzo MJ, Lasierra P, Larrad L, Marzo I, Naval J, Anel A.
    Eur J Immunol; 2005 Jun 30; 35(6):1812-21. PubMed ID: 15884050
    [Abstract] [Full Text] [Related]

  • 16. The involvement of TNF-alpha-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor cells.
    Liu S, Yu Y, Zhang M, Wang W, Cao X.
    J Immunol; 2001 May 01; 166(9):5407-15. PubMed ID: 11313377
    [Abstract] [Full Text] [Related]

  • 17. Resistance to Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines.
    Matsuda T, Almasan A, Tomita M, Uchihara JN, Masuda M, Ohshiro K, Takasu N, Yagita H, Ohta T, Mori N.
    J Virol; 2005 Feb 01; 79(3):1367-78. PubMed ID: 15650163
    [Abstract] [Full Text] [Related]

  • 18. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.
    Kayagaki N, Yamaguchi N, Nakayama M, Kawasaki A, Akiba H, Okumura K, Yagita H.
    J Immunol; 1999 Mar 01; 162(5):2639-47. PubMed ID: 10072506
    [Abstract] [Full Text] [Related]

  • 19. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.
    Koyama S, Koike N, Adachi S.
    J Cancer Res Clin Oncol; 2002 Feb 01; 128(2):73-9. PubMed ID: 11862476
    [Abstract] [Full Text] [Related]

  • 20. Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma.
    Dorothée G, Echchakir H, Le Maux Chansac B, Vergnon I, El Hage F, Moretta A, Bensussan A, Chouaib S, Mami-Chouaib F.
    Oncogene; 2003 Oct 16; 22(46):7192-8. PubMed ID: 14562047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.